Edgewise Therapeutics: Raymond James raises target price to $85 from $66
EWTX•Raymond James raised its target price for Edgewise Therapeutics to $85 from $66.
Related News
Wheaton Precious Metals credits higher gross margin for Q3 2026 net earnings growth
WPM•
Analysts and investors react to AI market rout
SPY•
Walker & Dunlop Inc: KBW raises target price to $48 from $43
WD•
Interparfums Inc: Canaccord Genuity raises target price to $154 from $151
IPAR•
KBW raises BILL Holdings price target to $58 from $52
BILL•